Searched over 200M research papers
10 papers analyzed
These studies suggest that ferritin levels are a reliable measure of iron storage and are useful for diagnosing iron deficiency and overload, with implications for various health conditions and treatment strategies.
19 papers analyzed
Iron is a crucial mineral for various bodily functions, including oxygen transport and DNA synthesis. Ferritin, a protein that stores iron, is a key indicator of the body's iron reserves. Low levels of iron and ferritin can lead to several health issues, including anemia and impaired cognitive and physical performance.
Ferritin levels in the blood provide a quantitative measure of the body's iron stores. Normal ferritin levels are typically around 69 ng/ml in men and 35 ng/ml in women. A ferritin concentration below 10 ng/ml is indicative of iron deficiency and is associated with low transferrin saturation and iron-deficient erythropoiesis. The World Health Organization (WHO) recommends using serum ferritin concentration as a biomarker to assess iron status in individuals and populations.
Ferritin is widely used in clinical practice to diagnose iron deficiency and overload. However, it is also an acute-phase protein, meaning its levels can be elevated in the presence of inflammation or infection, which can complicate the diagnosis. Studies have shown that ferritin levels below 30 µg/L are reasonably sensitive and specific for diagnosing iron deficiency in clinical settings. For iron overload, a ferritin concentration above 500 µg/L is often used as a threshold, although data is limited.
Recent advancements in machine learning have shown promise in predicting low ferritin levels. Algorithms developed using routine laboratory tests, such as complete blood count and C-reactive protein (CRP), have demonstrated high accuracy in identifying patients with low ferritin levels. These algorithms outperform specialists in laboratory medicine and can help in early diagnosis and treatment of iron deficiency.
Iron deficiency is particularly prevalent among women and children. In premenopausal women, factors such as menstruation, pregnancy, and parity significantly impact iron levels. Studies have shown that 18% of premenopausal women have exhausted iron reserves, and 2.6% suffer from iron deficiency anemia. In children, the prevalence of iron deficiency varies, but it is a significant concern during growth periods.
Blood donation is another factor that can lead to reduced iron stores. Ferritin-guided donation intervals have been proposed to prevent iron deficiency in donors. Implementing such policies can help maintain adequate iron levels and reduce the incidence of low-hemoglobin deferral.
Low ferritin levels have been associated with Restless Legs Syndrome (RLS), a condition that affects sleep and quality of life. Studies have shown that oral iron therapy can significantly improve RLS symptoms in patients with low-normal ferritin levels.
Low ferritin levels are also linked to an increased risk of heart failure. Research indicates that individuals with low ferritin levels have a higher incidence of heart failure compared to those with normal ferritin levels, suggesting that iron deficiency may play a role in the development of this condition.
Fatigue is a common symptom of iron deficiency, even in the absence of anemia. Intravenous iron therapy has been shown to improve fatigue in non-anemic women with low serum ferritin levels, particularly when ferritin is below 15 ng/ml.
Low iron and ferritin levels are significant health concerns that can lead to various conditions, including anemia, RLS, heart failure, and fatigue. Accurate diagnosis and timely intervention are crucial. Advances in diagnostic tools, such as machine learning algorithms, and targeted treatments, like ferritin-guided donation intervals and iron therapy, offer promising solutions to manage and mitigate the effects of iron deficiency.
Most relevant research papers on this topic